Autoimmune Life Blog

BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.

Learn about exciting new type 1 diabetes research Dr. Griffin is taking on at BRI.

Learn how a team led by Carla Greenbaum, MD, is using “fancy math” to better understand not only if a person will develop T1D, but when.

June 1, 2024, marked the second annual Benaroya Research Institute T1D Family Day.

Did you know that if risk screening results show you are in the early stages of T1D, you may be eligible to participate in a type 1 diabetes prevention study?

Learn about one of the first projects launched with this funding, where Eddie James, PhD, and Caroline Stephanie, PhD, are exploring a new approach to treat type 1 diabetes.

Hear from teenagers Clara and Gibson about their experience participating in research and why it's important to them.

Learn how Eddie James, PhD, Peter Morawski, PhD, and other BRI scientists are exploring tissue-specific immunology and why this approach is fueling discoveries.

"I know we will reach that golden age, and BRI’s research in human immunology is the vehi¬cle that will take us there. This field has shepherded incredible advances in recent years, including new vaccines, new cancer treatments, and new and better treatment options for autoimmune disease."

Participating in a clinical trial for type 1 diabetes (T1D) was easy for 9-year-old Mikaela. “Everyone was really nice. I just had to drink a milkshake with some medicine in it and get an IV.